#Libre – An example of ongoing variance within Diabetes care, looking at London area where this wasn’t supposed to happen…
A review of the variation across London in prescribing Libre.
A review of the variation across London in prescribing Libre.
If you’ve been looking at Diabetes technology recently, it’s hard not to have seen the recent news from Tandem about rolling out their Predictive Low […]
It’s hard not to have seen the recent Twitter and blog campaign that came about as the result of Grumpy Pumper’s diagnosis of a foot […]
In the UK, at least 82 people (as of the date of publishing) are using DIY APS systems to manage their diabetes. Of these, the majority are using AndroidAPS.
Around the time of launching Fiasp, Novo Nordisk embarked on a wider study of its use in Continuous Subcutaneous Insulin Infusion (CSII), or pumping as […]
Over the past eight months, Nemaura have announced a number of outcomes of their clinical trials, all of which have suggested that after a tricky […]
If you’re a person with Type 1 Diabetes, it’s very hard not to have seen the news about Sir Michael Rawlins’ (Chair of the UK […]
If you keep your eyes on Diabetes and medical media, you can’t fail to have noticed that Roche’s Solo Micropump, a new patch pump from […]
Back at the end of March, when Dexcom launched the G6, I questioned how this might affect those using WeAreNotWaiting open source Diabetes technology. It […]
After six months of leaving Fiasp on the shelf, and occasionally using it as an adjunct injection when fast carbs were consumed (where it still […]
Copyright © 2026 | WordPress Theme by MH Themes